Landmark hormone replacement therapy study stopped after finding more harms than benefits.
Rollins
Gina
G
D000368:Aged; D001943:Breast Neoplasms / Q000139:chemically induced; D002318:Cardiovascular Diseases / Q000139:chemically induced; D026661:Clinical Trials Data Monitoring Committees; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000517:prevention & control; D003362:Cost-Benefit Analysis; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D004967:Estrogens / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D050723:Fractures, Bone / Q000517:prevention & control; D020249:Hormone Replacement Therapy / Q000009:adverse effects*; D006801:Humans; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000188:drug therapy / Q000517:prevention & control; D017698:Postmenopause / Q000187:drug effects*; D017410:Practice Guidelines as Topic; D011372:Progestins / Q000009:adverse effects* / Q000627:therapeutic use; D014481:United States
D004967:Estrogens; D011372:Progestins